GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 1ADE05
Of the Field

BIO International 2026

B

IO International 2026 is the industry's largest partnering conference representing the full biotech ecosystem, taking place at the San Diego Convention Center. The event brings together biopharma teams to deliver integrated solutions, accelerate clinical development, reduce risks, and improve commercialization outcomes. Featuring a wide range of insights, n…

Visit the official site
11Voices
59Underwriters
0Exhibitors
0On the bill · sessions
67Companies · in total
§I

The Voices

Programmed at BIO, in alphabetical order.
Cynthia Isaac, PhD
Moderator
Gyu Hyun (George) NAM
CBO · DigmBio
John C. Reed
Executive Vice President, Innovative Medicine, R&D · Johnson & Johnson
Max Wang
BD · Mote Therapeutics
Nauman Shah
Global Head of Business Development · Johnson & Johnson
Rick Riedstra
Project Manager Life Sciences & Health · Netherlands Foreign Investment Agency
Sandy Mou
Board Executive Director and Chief Executive Officer · CORXEL
Sigrún Elfa Snæbjörnsdóttir
Nordic Community Manager · SwedenBIO
Tara Dalton
Dr Tara Dalton · Altratech Ltd
Vuong Trieu
CEO · Sapu
Yoh Terada
CSO · Alivexis, Inc.
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
AbbVie Inc.Conference
ACADIA Pharmaceuticals, IncConference
AiluxChampion
AlixPartnersChampion
Alnylam PharmaceuticalsConference
AmgenDouble Helix
Asahi Kasei Therapeutics CorporationConference
AstraZenecaChampion
BioMarinChampion
Boehringer IngelheimHelix
Bora BiologicsChampion
BOSTAL LLCConference
Catalyst PharmaceuticalsChampion
ChubbChampion
City of PhoenixConference
Daiichi SankyoPremier
DNB Carnegie | Back Bay HealthcareConference
Eli Lilly and CompanyDouble Helix
EnzeneConference
Ergomed Clincal ResearchConference
EversanaConference
FujifilmChampion
GenentechDouble Helix
IDT BiologikaConference
InpharmusConference
Invest Puerto RicoPremier
JobsOhioConference
Johnson & JohnsonPremier
KindevaConference
KyboraConference
Kyoto UniversityConference
LabcorpConference
Life Sciences PennsylvaniaConference
MerckDouble Helix
New York StateConference
NovartisPremier
Novo NordiskHelix
NovotechConference
Nxera PharmaPremier
OcugenConference
Intermission
Part the Second · For the Buyer

What does it mean when 67 companies show up — and 1 bet on three roles at once?

“67 companies. one are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
1All threespeak · spons · exh
58Sponsoringsponsor only
0Exhibitingexhibitor only
8Speakingspeaker only

The Triple-Threat

Johnson & Johnson

№ 02Fig. 02 — The Voices, by Seniority

36% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite218%
  • VP-level19%
  • Director / Head of19%
  • Manager / Lead218%
  • Other roles545%

Of 11 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01Johnson & JohnsonSp·P2V
  2. 02AbbVieSp·C
  3. 03Acadia PharmaceuticalsSp·C
  4. 04AiluxSp·C
  5. 05AlixPartnersSp·C
  6. 06Alnylam PharmaceuticalsSp·C
  7. 07AmgenSp·D
  8. 08Asahi Kasei Therapeutics CorporationSp·C
  9. 09AstraZenecaSp·C
  10. 10BioMarinSp·C
  11. 11Boehringer IngelheimSp·H
  12. 12Bora BiologicsSp·C
  13. 13BOSTAL LLCSp·C
  14. 14Catalyst PharmaceuticalsSp·C
№ 04Fig. 04 — By Tier
champion16
27% of 59
conference26
44% of 59
double helix6
10% of 59
helix2
3% of 59
premier9
15% of 59
№ 05Fig. 05 — The Missing · who's at peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

№ 06Fig. 06 — Adjacent Convocations · by shared underwriters